Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-02

Clinical Trial Update: Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating drug levels of tablet and liquid lamivudine, nevirapine, and stavudine in HIV-infected Thai children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)
  • NEVIRAPINE (nevirapine)
  • stavudine (stavudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED